테바 ADR (TEVA)

Teva- Pharmaceutical Industries Ltd. ADR 주식(TEVA)의 최신 뉴스

A company insider recently sold 15219 shares of Teva- Pharmaceutical Industries Ltd. ADR [TEVA]. Should You Sale ... - Knox Daily

Knox Daily

Teva- Pharmaceutical Industries Ltd. ADR (NYSE: TEVA) Has Great Upside Potential – Stocks Register - Stocks Register

Stocks Register

2024-05-15 | NYSE:TEVA | Press Release | Teva Pharmaceutical Industries ADR Representing One - Stockhouse Publishing

Stockhouse Publishing

There is no doubt that Teva- Pharmaceutical Industries Ltd. ADR (TEVA) ticks all the boxes. – Sete News - SETE News

SETE News

Is Aldeyra Therapeutics (ALDX) Stock Outpacing Its Medical Peers This Year?

Zacks Investment Research

TEVA Stock: A Comprehensive Analysis and Forecast - The InvestChronicle

The InvestChronicle

TEVA's price-to-cash ratio: How it affects the stock's valuation. – US Post News - US Post News

US Post News

TEVA Q1 Earnings Miss, Schizophrenia Study Meets Goal, Stock Up

Zacks Investment Research

Teva Earnings: Despite Mixed First Quarter Results Shares Rally on Good Readout for Olanzapine - Morningstar

Morningstar

Teva's Long-Term Outlook Looks Promising on Biosimilar Wins and Growing, Innovative Portfolio - Morningstar

Morningstar

Teva Pharmaceutical Industries (TEVA) Q1 2024 Earnings Call Transcript

The Motley Fool

Teva Pharmaceutical Industries (TEVA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Zacks Investment Research

Wall Street Poised For Muted Open On Mixed Earnings, With More Fed Speeches In Store: Analyst Sees S&P 500 Crossing Late-March High

Benzinga

Teva's Long-Term Outlook Looks Promising on Biosimilar Wins and Growing, Innovative Portfolio - Morningstar

Morningstar

Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?

Zacks Investment Research

Red Light, Green Light: 2 Things to Know Before Buying Teva Pharmaceutical Industries Ltd (ADR) Stoc - AOL

AOL

Understanding TEVA stock ratios for better investment decisions – US Post News - US Post News

US Post News

Unlocking Q1 Potential of Teva Pharmaceutical Industries (TEVA): Exploring Wall Street Estimates for Key Metrics

Zacks Investment Research

Zacks Industry Outlook Highlights Teva, Dr. Reddy's and Viatris

Zacks Investment Research

Our Attention Has Been Attracted to Teva- Pharmaceutical Industries Ltd. ADR (NYSE:TEVA) – US Post News - US Post News

US Post News

3 Generic Drug Stocks to Watch Amid Challenging Market Prospects

Zacks Investment Research

Forget Nvidia: 3 Prominent Billionaire Investors Are Selling It and Buying These 6 Value Stocks Instead

The Motley Fool

3 No-Brainer Stocks to Buy With $600 Right Now

The Motley Fool

Bausch (BHC) Soars 6.4%: Is Further Upside Left in the Stock?

Zacks Investment Research

Will Corcept (CORT) Bank on Korlym in 2024 Amid Stiff Rivalry?

Zacks Investment Research

Cramer Isn't 'Knocking' This Pharma Firm Anymore: 'As A Matter Of Fact, I'm Going In'

Benzinga

GSK Follows Rivals, to Cap Out-of-Pocket Inhaler Cost in US

Zacks Investment Research

AstraZeneca (AZN) Follows Boehringer, to Cap Inhaler Cost in US

Zacks Investment Research

J&J (JNJ) Seeks Expanded Use of Tremfya for Ulcerative Colitis

Zacks Investment Research

8 Analysts Assess Teva Pharmaceutical Indus: What You Need To Know

Benzinga

Rare Stock Picks In February 2024 - From 32 Discerning Analysts

Seeking Alpha

TEVA: 3 Pharma Stocks to Consider for March Gains - StockNews.com

StockNews.com

Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Benzinga

Li Auto Posts Q4 Earnings, Joins Teva Pharmaceutical And Other Big Stocks Moving Higher In Monday's Pre-Market Session

Benzinga

Teva: Biosimilar to Humira Finally Seals US Approval; Looks to Be Best in Class in a Crowded Market - Morningstar

Morningstar

David Einhorn’s Greenlight Capital adds Kenvue, ETFs and exits Southwestern Energy

MarketWatch

Why This Teva Pharmaceutical Analyst Is Turning Bullish On The Austedo Franchise

Benzinga

CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday

Benzinga

Teva Pharmaceutical To Rally Around 58%? Here Are 10 Top Analyst Forecasts For Monday

Benzinga

Beyond The Numbers: 8 Analysts Discuss Teva Pharmaceutical Indus Stock

Benzinga

TEVA Q4 Earnings and Revenues Surpass Estimates, Stock Up

Zacks Investment Research

Teva Pharmaceutical Industries (TEVA) Q4 2023 Earnings Call Transcript

The Motley Fool

Boeing Posts Upbeat Results, Joins Stryker, Automatic Data Processing And Other Big Stocks Moving Higher On Wednesday

Benzinga

Teva Pharmaceutical Industries Ltd. (TEVA) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Investment Research

Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser

Benzinga

Nasdaq Futures Plummet As Alphabet, AMD Disappointments Sour Sentiment; Spotlight Shifts To Fed Statement, Powell's Presser

Benzinga

Teva Earnings: Turnaround Year Ends With Strong Quarter as Sales Growth Returns - Morningstar

Morningstar

Unveiling Teva Pharmaceutical Industries Ltd. (TEVA) Q4 Outlook: Wall Street Estimates for Key Metrics

Zacks Investment Research

Zacks Industry Outlook Highlights Amphastar, Teva and Dr. Reddy's

Zacks Investment Research

3 Generic Drug Stocks to Watch Amid Improving Market Prospects

Zacks Investment Research